Bruker Says 'Material Weakness' at Subsidiary
Will Force Firm to Raise 2004 Losses

A "material weakness in internal controls" at an undisclosed Bruker BioSciences subsidiary will cause Bruker to increase its 2004 net losses, the company said.

According to a statement released Wednesday, Bruker said it has been made aware of several 2004 audit adjustments that it said will have a negative impact on its 2004 financial results.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.

NPR reports that government and private insurers are being slow to cover recently approved CAR-T cell therapies.

CNBC reports that there are thousands of genetic tests available for consumers to chose between.

In Nature this week: genomic analysis of ducks, whole-genome doubling among tumor samples, and more.